Submit Deal

AVICEDA THERAPEUTICS

HQ - Cambridge

Summary

Aviceda is a private, clinical-stage biotechnology company.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 166 M

Avg. Deal Size£ 166 M

Market Context

Senior Management

Sort

Target: AVICEDA THERAPEUTICS

Bidder: OMEGA FUNDS

8 Service Providers

4 Dealmakers

£ 166 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy